References
1. Temporary guidelines. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version11 (07.05.21). Ministry of Health of the Russian Federation; 225 p. (in Russian)
2. Li X., et al. Potential of large «first generation» human-to-human transmission of 2019-nCoV. J Med Virol. 2020; 92 (4): 448–54. DOI: https://doi.org/10.1002/jmv.25693
3. World Health Organization. Infection prevention and control guidance for long-term care facilities in the context of COVID-19: interim guidance, 21 March 2020. World Health Organization, 2020.
4. Wambier C.G., Goren A. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated. J Am Acad Dermatol. 2020; 83 (1): 308-9. DOI: https://doi.org/10.1016/jjaad.2020.04.032
5. Manning J.T., Fink B. Digit ratio, nicotine and alcohol intake and national rates of smoking and alcohol consumption. Pers Individ Differ. 2011; 50 (3): 344-8. DOI: https://doi.org/10.1016/j.paid.2010.10.016
6. Wambier C.G., Goren A., Vaco-Galvan S., et al. Androgen sensitivity gateway to COVID-19 disease severity. Drug Dev Res. 2020; 81 (7): 771-6. DOI: https://doi.org/10.1002/ddr.21688
7. Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., et al. Post-COVID syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021; 372: n693. DOI: https://doi.org/10.1136/bmj.n693 PMID: 33789877; PMCID: PMC 8010267.
8. Heinemann L.A., Saad F., Zimmermann T., et al. The Aging Males’ Symptoms (AMS) scale: update and compilation of international versions. Health Qual Life Outcomes. 2003; 1: 15. DOI: https://doi.org/10.1186/1477-7525-1-15
9. Dedov I.I., Mel’nichenko G.A., Shestakova M.V., Rozhivanov R.V., Terehova A.L., Zilov A.V., et al. Guidelines for the Diagnosis and Treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus. Ozhirenie i metabolizm [Obesity and Metabolism]. 2017; 14 (4): 83-92. DOI: https://doi.org/10.14341/omet2017483-92 (in Russian)
10. Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021; 397 (10 270): 220-32. DOI: https://doi.org/10.1016/S0140-6736(20)32656-8 Epub 2021 Jan 8. PMID: 33428867; PMCID: PMC 7833295.
11. Sigfrid L., Drake T.M., Pauley E., Jesudason E.C., Olliaro P., Lim W.S., et al.; ISARIC 4C investigators. Long COVID in adults discharged from UK hospitals after COVID-19: a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg Health Eur. 2021; Aug 6: 100186. DOI: https://doi.org/10.1016/j.lanepe.2021.100186 Epub ahead of print. PMID: 34386785; PMCID: PMC 8343377.
12. Dedov I.I., Shestakova M.V. Type 2 diabetes mellitus: from theory to practice. Moscow: MIA, 2016: 576 p. (in Russian)
13. Dedov I.I., Shestakova M.V., Mayorov A. Yu., Vikulova O.K., Gal-styan G.R., Kuraeva T.L., et al. Standards of specialized diabetes care. In: I.I. Dedov, M.V. Shestakova, A. Yu. Mayorov (eds). 9th ed. Sakharniy diabet [Diabetes Mellitus]. 2019; 22 (1S 1): 1-144. DOI: https://doi.org/10.14341/DM221S1 (in Russian)
14. Janiri D., Kotzalidis G.D., Giuseppin G., Molinaro M., Modica M., Montanari S., et al.; Gemelli Against COVID-19 Post-Acute Care Study Group. Psychological distress after COVID-19 recovery: reciprocal effects with temperament and emotional dysregulation. an exploratory study of patients over 60 years of age assessed in a post-acute care service. Front Psychiatry. 2020; 11: 590135. DOI: https://doi.org/10.3389/fpsyt.2020.590135 PMID: 33304286; PMCID: PMC 7693440.
15. Rastrelli G., Di Stasi V., Inglese F., Beccaria M., Garuti M., Di Cos-tanzo D., et al. Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients. Andrology. 2021; 9 (1): 88-98. DOI: https://doi.org/10.1111/andr.12821 PMID: 32436355
16. Moreno-Perez O., Merino E., Alfayate R., Torregrosa M.E., Andres M., Leon-Ramirez J.M., et al.; COVID 19-ALC Research Group. Male pituitary-gonadal axis dysfunction in post-acute COVID-19 syndrome. Prevalence and associated factors: A Mediterranean Case Series. Clin Endocrinol (Oxf). 2021; Jun 23. DOI: https://doi.org/10.1111/cen.14537 Epub ahead of print. PMID: 34160836.
17. Das L., Dutta P., Walia R., Mukherjee S., Suri V., Puri G.D., et al. Spectrum of endocrine dysfunction and association with disease severity in patients with COVID-19: insights from a cross-sectional, observational study. Front Endocrinol (Lausanne). 2021; 12: 645787. DOI: https://doi.org/10.3389/fendo.2021.645787 PMID: 34276556; PMCID: PMC 8283965.
18. Hodgson S.H., Mansatta K., Mallett G., Harris V., Emary K.R.W., Pollard A.J. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet Infect Dis. 2021; 21 (2): e26-35. DOI: https://doi.org/10.1016/S1473-3099(20)30773-8 Epub 2020 Oct 27. PMID: 33125914; PMCID: PMC 7837315.